Discovery in Genetic Skin Disease: The Impact of High Throughput Genetic Technologies
AbstractThe last decade has seen considerable advances in our understanding of the genetic basis of skin disease, as a consequence of high throughput sequencing technologies including next generation sequencing and whole exome sequencing. We have now determined the genes underlying several monogenic diseases, such as harlequin ichthyosis, Olmsted syndrome, and exfoliative ichthyosis, which have provided unique insights into the structure and function of the skin. In addition, through genome wide association studies we now have an understanding of how low penetrance variants contribute to inflammatory skin diseases such as psoriasis vulgaris and atopic dermatitis, and how they contribute to underlying pathophysiological disease processes. In this review we discuss strategies used to unravel the genes underlying both monogenic and complex trait skin diseases in the last 10 years and the implications on mechanistic studies, diagnostics, and therapeutics. View Full-Text
Share & Cite This Article
Maruthappu, T.; Scott, C.A.; Kelsell, D.P. Discovery in Genetic Skin Disease: The Impact of High Throughput Genetic Technologies. Genes 2014, 5, 615-634.
Maruthappu T, Scott CA, Kelsell DP. Discovery in Genetic Skin Disease: The Impact of High Throughput Genetic Technologies. Genes. 2014; 5(3):615-634.Chicago/Turabian Style
Maruthappu, Thiviyani; Scott, Claire A.; Kelsell, David P. 2014. "Discovery in Genetic Skin Disease: The Impact of High Throughput Genetic Technologies." Genes 5, no. 3: 615-634.